Tekmira Pharmaceuticals Corporation logo
Exited company

Tekmira Pharmaceuticals Corporation

Details
Region
Prairies and West
Industry sector
Biotechnology
Investment year
2002
Fund
Healthcare Venture Fund
About the company

Tekmira is a leader in the development of the therapeutic agents based upon Nobel prize-winning breakthroughs in the field of gene silencing, known as RNA interference (RNAi). Tekmira’s three lead RNAi product candidates target cholesterol management, cancer and Ebola infection.